[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f16yyl5e2hlvzn":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":42,"exclusivities":43,"paragraphIv":44,"catalysts":46},"ACTOS","PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","takeda-pharms-usa",[20],"021073","none",3,0,[25,34,38],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021073-001","001","TABLET","ORAL","EQ 15MG BASE","1999-07-15","AB","RX",{"key":35,"applNo":20,"productNo":36,"dosageForm":28,"route":29,"strength":37,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021073-002","002","EQ 30MG BASE",{"key":39,"applNo":20,"productNo":40,"dosageForm":28,"route":29,"strength":41,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021073-003","003","EQ 45MG BASE",[],[],{"asOf":12,"firstFiled":12,"entries":45},[],[]]